Sleep loss and addiction
Reducing sleep hours is a risk factor for developing cardiovascular, metabolic, and psychiatric disorders. Furthermore, previous studies have shown that reduction in sleep time is a factor that favors relapse in addicted patients. Additionally, animal models have demonstrated that both sleep restric...
Gespeichert in:
Veröffentlicht in: | Neuroscience and biobehavioral reviews 2022-10, Vol.141, p.104832-104832, Article 104832 |
---|---|
Hauptverfasser: | , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 104832 |
---|---|
container_issue | |
container_start_page | 104832 |
container_title | Neuroscience and biobehavioral reviews |
container_volume | 141 |
creator | López-Muciño, Luis Angel García-García, Fabio Cueto-Escobedo, Jonathan Acosta-Hernández, Mario Venebra-Muñoz, Arturo Rodríguez-Alba, Juan Carlos |
description | Reducing sleep hours is a risk factor for developing cardiovascular, metabolic, and psychiatric disorders. Furthermore, previous studies have shown that reduction in sleep time is a factor that favors relapse in addicted patients. Additionally, animal models have demonstrated that both sleep restriction and sleep deprivation increase the preference for alcohol, methylphenidate, and the self-administration of cocaine. Therefore, the present review discusses current knowledge about the influence of sleep hours reduction on addictivebehaviors; likewise, we discuss the neuronal basis underlying the sleep reduction-addiction relationship, like the role of the orexin and dopaminergic system and neuronal plasticity (i.e., delta FosB expression). Potentially, chronic sleep restriction could increase brain vulnerability and promote addictive behavior.
[Display omitted]
•The reduction of sleep hours in contemporary society can be a factor that facilitates the consumption of addictive substances.•Orexins' overstimulation of VTA neurons due to prolonged wakefulness leads to sensitization of the reward circuit.•Sleep loss potentially detonates neuronal plasticity that facilitate the development of addictive behavior. |
doi_str_mv | 10.1016/j.neubiorev.2022.104832 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2705398145</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0149763422003219</els_id><sourcerecordid>2705398145</sourcerecordid><originalsourceid>FETCH-LOGICAL-c278t-20f7e7baaee80c5e486e9eb1c4a7e44b879935c685931ef8a2ab1450f9f264c73</originalsourceid><addsrcrecordid>eNqFkE1LxDAQhoMouK7evblHL62TryY5LotfsOBBPYc0nUKWbrMm7YL_3i4Vr54Ghvd5mXkIuaNQUqDVw67scaxDTHgsGTA2bYXm7IwsqFa8UJLpc7IAKkyhKi4uyVXOOwBgwOWC3L53iIdVF3Neub5ZuaYJfgixvyYXresy3vzOJfl8evzYvBTbt-fXzXpbeKb0UDBoFaraOUQNXqLQFRqsqRdOoRC1VsZw6SstDafYasdcTYWE1rSsEl7xJbmfew8pfo2YB7sP2WPXuR7jmC1TILnREzNF1Rz1aTo3YWsPKexd-rYU7MmF3dk_F_bkws4uJnI9kzh9cgyYbPYBe49NSOgH28Twb8cPBa9qdQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2705398145</pqid></control><display><type>article</type><title>Sleep loss and addiction</title><source>Elsevier ScienceDirect Journals</source><creator>López-Muciño, Luis Angel ; García-García, Fabio ; Cueto-Escobedo, Jonathan ; Acosta-Hernández, Mario ; Venebra-Muñoz, Arturo ; Rodríguez-Alba, Juan Carlos</creator><creatorcontrib>López-Muciño, Luis Angel ; García-García, Fabio ; Cueto-Escobedo, Jonathan ; Acosta-Hernández, Mario ; Venebra-Muñoz, Arturo ; Rodríguez-Alba, Juan Carlos</creatorcontrib><description>Reducing sleep hours is a risk factor for developing cardiovascular, metabolic, and psychiatric disorders. Furthermore, previous studies have shown that reduction in sleep time is a factor that favors relapse in addicted patients. Additionally, animal models have demonstrated that both sleep restriction and sleep deprivation increase the preference for alcohol, methylphenidate, and the self-administration of cocaine. Therefore, the present review discusses current knowledge about the influence of sleep hours reduction on addictivebehaviors; likewise, we discuss the neuronal basis underlying the sleep reduction-addiction relationship, like the role of the orexin and dopaminergic system and neuronal plasticity (i.e., delta FosB expression). Potentially, chronic sleep restriction could increase brain vulnerability and promote addictive behavior.
[Display omitted]
•The reduction of sleep hours in contemporary society can be a factor that facilitates the consumption of addictive substances.•Orexins' overstimulation of VTA neurons due to prolonged wakefulness leads to sensitization of the reward circuit.•Sleep loss potentially detonates neuronal plasticity that facilitate the development of addictive behavior.</description><identifier>ISSN: 0149-7634</identifier><identifier>EISSN: 1873-7528</identifier><identifier>DOI: 10.1016/j.neubiorev.2022.104832</identifier><language>eng</language><publisher>Elsevier Ltd</publisher><subject>Delta FosB ; Dopamine ; Drug consumption ; Insomnia ; Neuronal plasticity ; Orexin ; Sleep deprivation</subject><ispartof>Neuroscience and biobehavioral reviews, 2022-10, Vol.141, p.104832-104832, Article 104832</ispartof><rights>2022 Elsevier Ltd</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c278t-20f7e7baaee80c5e486e9eb1c4a7e44b879935c685931ef8a2ab1450f9f264c73</citedby><cites>FETCH-LOGICAL-c278t-20f7e7baaee80c5e486e9eb1c4a7e44b879935c685931ef8a2ab1450f9f264c73</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0149763422003219$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3536,27903,27904,65309</link.rule.ids></links><search><creatorcontrib>López-Muciño, Luis Angel</creatorcontrib><creatorcontrib>García-García, Fabio</creatorcontrib><creatorcontrib>Cueto-Escobedo, Jonathan</creatorcontrib><creatorcontrib>Acosta-Hernández, Mario</creatorcontrib><creatorcontrib>Venebra-Muñoz, Arturo</creatorcontrib><creatorcontrib>Rodríguez-Alba, Juan Carlos</creatorcontrib><title>Sleep loss and addiction</title><title>Neuroscience and biobehavioral reviews</title><description>Reducing sleep hours is a risk factor for developing cardiovascular, metabolic, and psychiatric disorders. Furthermore, previous studies have shown that reduction in sleep time is a factor that favors relapse in addicted patients. Additionally, animal models have demonstrated that both sleep restriction and sleep deprivation increase the preference for alcohol, methylphenidate, and the self-administration of cocaine. Therefore, the present review discusses current knowledge about the influence of sleep hours reduction on addictivebehaviors; likewise, we discuss the neuronal basis underlying the sleep reduction-addiction relationship, like the role of the orexin and dopaminergic system and neuronal plasticity (i.e., delta FosB expression). Potentially, chronic sleep restriction could increase brain vulnerability and promote addictive behavior.
[Display omitted]
•The reduction of sleep hours in contemporary society can be a factor that facilitates the consumption of addictive substances.•Orexins' overstimulation of VTA neurons due to prolonged wakefulness leads to sensitization of the reward circuit.•Sleep loss potentially detonates neuronal plasticity that facilitate the development of addictive behavior.</description><subject>Delta FosB</subject><subject>Dopamine</subject><subject>Drug consumption</subject><subject>Insomnia</subject><subject>Neuronal plasticity</subject><subject>Orexin</subject><subject>Sleep deprivation</subject><issn>0149-7634</issn><issn>1873-7528</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><recordid>eNqFkE1LxDAQhoMouK7evblHL62TryY5LotfsOBBPYc0nUKWbrMm7YL_3i4Vr54Ghvd5mXkIuaNQUqDVw67scaxDTHgsGTA2bYXm7IwsqFa8UJLpc7IAKkyhKi4uyVXOOwBgwOWC3L53iIdVF3Neub5ZuaYJfgixvyYXresy3vzOJfl8evzYvBTbt-fXzXpbeKb0UDBoFaraOUQNXqLQFRqsqRdOoRC1VsZw6SstDafYasdcTYWE1rSsEl7xJbmfew8pfo2YB7sP2WPXuR7jmC1TILnREzNF1Rz1aTo3YWsPKexd-rYU7MmF3dk_F_bkws4uJnI9kzh9cgyYbPYBe49NSOgH28Twb8cPBa9qdQ</recordid><startdate>202210</startdate><enddate>202210</enddate><creator>López-Muciño, Luis Angel</creator><creator>García-García, Fabio</creator><creator>Cueto-Escobedo, Jonathan</creator><creator>Acosta-Hernández, Mario</creator><creator>Venebra-Muñoz, Arturo</creator><creator>Rodríguez-Alba, Juan Carlos</creator><general>Elsevier Ltd</general><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>202210</creationdate><title>Sleep loss and addiction</title><author>López-Muciño, Luis Angel ; García-García, Fabio ; Cueto-Escobedo, Jonathan ; Acosta-Hernández, Mario ; Venebra-Muñoz, Arturo ; Rodríguez-Alba, Juan Carlos</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c278t-20f7e7baaee80c5e486e9eb1c4a7e44b879935c685931ef8a2ab1450f9f264c73</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Delta FosB</topic><topic>Dopamine</topic><topic>Drug consumption</topic><topic>Insomnia</topic><topic>Neuronal plasticity</topic><topic>Orexin</topic><topic>Sleep deprivation</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>López-Muciño, Luis Angel</creatorcontrib><creatorcontrib>García-García, Fabio</creatorcontrib><creatorcontrib>Cueto-Escobedo, Jonathan</creatorcontrib><creatorcontrib>Acosta-Hernández, Mario</creatorcontrib><creatorcontrib>Venebra-Muñoz, Arturo</creatorcontrib><creatorcontrib>Rodríguez-Alba, Juan Carlos</creatorcontrib><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Neuroscience and biobehavioral reviews</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>López-Muciño, Luis Angel</au><au>García-García, Fabio</au><au>Cueto-Escobedo, Jonathan</au><au>Acosta-Hernández, Mario</au><au>Venebra-Muñoz, Arturo</au><au>Rodríguez-Alba, Juan Carlos</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Sleep loss and addiction</atitle><jtitle>Neuroscience and biobehavioral reviews</jtitle><date>2022-10</date><risdate>2022</risdate><volume>141</volume><spage>104832</spage><epage>104832</epage><pages>104832-104832</pages><artnum>104832</artnum><issn>0149-7634</issn><eissn>1873-7528</eissn><abstract>Reducing sleep hours is a risk factor for developing cardiovascular, metabolic, and psychiatric disorders. Furthermore, previous studies have shown that reduction in sleep time is a factor that favors relapse in addicted patients. Additionally, animal models have demonstrated that both sleep restriction and sleep deprivation increase the preference for alcohol, methylphenidate, and the self-administration of cocaine. Therefore, the present review discusses current knowledge about the influence of sleep hours reduction on addictivebehaviors; likewise, we discuss the neuronal basis underlying the sleep reduction-addiction relationship, like the role of the orexin and dopaminergic system and neuronal plasticity (i.e., delta FosB expression). Potentially, chronic sleep restriction could increase brain vulnerability and promote addictive behavior.
[Display omitted]
•The reduction of sleep hours in contemporary society can be a factor that facilitates the consumption of addictive substances.•Orexins' overstimulation of VTA neurons due to prolonged wakefulness leads to sensitization of the reward circuit.•Sleep loss potentially detonates neuronal plasticity that facilitate the development of addictive behavior.</abstract><pub>Elsevier Ltd</pub><doi>10.1016/j.neubiorev.2022.104832</doi><tpages>1</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0149-7634 |
ispartof | Neuroscience and biobehavioral reviews, 2022-10, Vol.141, p.104832-104832, Article 104832 |
issn | 0149-7634 1873-7528 |
language | eng |
recordid | cdi_proquest_miscellaneous_2705398145 |
source | Elsevier ScienceDirect Journals |
subjects | Delta FosB Dopamine Drug consumption Insomnia Neuronal plasticity Orexin Sleep deprivation |
title | Sleep loss and addiction |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-25T08%3A37%3A11IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Sleep%20loss%20and%20addiction&rft.jtitle=Neuroscience%20and%20biobehavioral%20reviews&rft.au=L%C3%B3pez-Muci%C3%B1o,%20Luis%20Angel&rft.date=2022-10&rft.volume=141&rft.spage=104832&rft.epage=104832&rft.pages=104832-104832&rft.artnum=104832&rft.issn=0149-7634&rft.eissn=1873-7528&rft_id=info:doi/10.1016/j.neubiorev.2022.104832&rft_dat=%3Cproquest_cross%3E2705398145%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2705398145&rft_id=info:pmid/&rft_els_id=S0149763422003219&rfr_iscdi=true |